img

Global Antiviral Traditional Chinese Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antiviral Traditional Chinese Medicine Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Antiviral traditional Chinese medicine (TCM) refers to herbal remedies and formulations used in traditional Chinese medicine to treat viral infections and boost the immune system.
Antiviral Traditional Chinese Medicine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antiviral Traditional Chinese Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Adult and Children are the major drivers for the industry.
The market for antiviral traditional Chinese medicine is driven by the growing interest in natural and alternative treatments for viral infections. Traditional Chinese medicine has a long history of using herbal remedies to support immune health and treat various ailments. As consumers seek natural and complementary health solutions, the market for antiviral TCM is expected to grow.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antiviral Traditional Chinese Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Guangzhou Pharmaceutical
CR SANJIU
TASLY
China TCM
Yunnan Baiyao
Tongrentang
Jumpcan
Zhejiang Conba Pharmaceutical
Green Valley Pharma
Changbaishan Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
Qingfeng Pharmaceutical Group
Buchang Pharmaceutical
Livzon
ZBD Pharmaceutical
Chase Sun Pharmaceutical
Wuzhou Pharmaceutical
Yusheng Pharmaceutical
Harbin Pharmaceutical Group
Fusen Pharmaceutical
Gerun Pharmaceutical
Shineway Pharmaceutical
Yiling Pharmaceutical
Harbin Pharmaceutical Group
Segment by Type
Anti-HIV
Anti-CVB
Anti-HBV
Anti-influenza Virus
Anti-herpes Virus
Other

Segment by Application


Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antiviral Traditional Chinese Medicine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antiviral Traditional Chinese Medicine introduction, etc. Antiviral Traditional Chinese Medicine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Antiviral Traditional Chinese Medicine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Antiviral Traditional Chinese Medicine
1.1 Antiviral Traditional Chinese Medicine Market Overview
1.1.1 Antiviral Traditional Chinese Medicine Product Scope
1.1.2 Antiviral Traditional Chinese Medicine Market Status and Outlook
1.2 Global Antiviral Traditional Chinese Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Antiviral Traditional Chinese Medicine Market Size by Region (2018-2029)
1.4 Global Antiviral Traditional Chinese Medicine Historic Market Size by Region (2018-2024)
1.5 Global Antiviral Traditional Chinese Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Antiviral Traditional Chinese Medicine Market Size (2018-2029)
1.6.1 North America Antiviral Traditional Chinese Medicine Market Size (2018-2029)
1.6.2 Europe Antiviral Traditional Chinese Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size (2018-2029)
1.6.4 Latin America Antiviral Traditional Chinese Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size (2018-2029)
2 Antiviral Traditional Chinese Medicine Market by Type
2.1 Introduction
2.1.1 Anti-HIV
2.1.2 Anti-CVB
2.1.3 Anti-HBV
2.1.4 Anti-influenza Virus
2.1.5 Anti-herpes Virus
2.1.6 Other
2.2 Global Antiviral Traditional Chinese Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Antiviral Traditional Chinese Medicine Historic Market Size by Type (2018-2024)
2.2.2 Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Antiviral Traditional Chinese Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Antiviral Traditional Chinese Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Antiviral Traditional Chinese Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Antiviral Traditional Chinese Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Antiviral Traditional Chinese Medicine Revenue Breakdown by Type (2018-2029)
3 Antiviral Traditional Chinese Medicine Market Overview by Application
3.1 Introduction
3.1.1 Adult
3.1.2 Children
3.2 Global Antiviral Traditional Chinese Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Antiviral Traditional Chinese Medicine Historic Market Size by Application (2018-2024)
3.2.2 Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Antiviral Traditional Chinese Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Antiviral Traditional Chinese Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Antiviral Traditional Chinese Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Antiviral Traditional Chinese Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Antiviral Traditional Chinese Medicine Revenue Breakdown by Application (2018-2029)
4 Antiviral Traditional Chinese Medicine Competition Analysis by Players
4.1 Global Antiviral Traditional Chinese Medicine Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiviral Traditional Chinese Medicine as of 2022)
4.3 Date of Key Players Enter into Antiviral Traditional Chinese Medicine Market
4.4 Global Top Players Antiviral Traditional Chinese Medicine Headquarters and Area Served
4.5 Key Players Antiviral Traditional Chinese Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Antiviral Traditional Chinese Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Guangzhou Pharmaceutical
5.1.1 Guangzhou Pharmaceutical Profile
5.1.2 Guangzhou Pharmaceutical Main Business
5.1.3 Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.1.4 Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.1.5 Guangzhou Pharmaceutical Recent Developments
5.2 CR SANJIU
5.2.1 CR SANJIU Profile
5.2.2 CR SANJIU Main Business
5.2.3 CR SANJIU Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.2.4 CR SANJIU Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.2.5 CR SANJIU Recent Developments
5.3 TASLY
5.3.1 TASLY Profile
5.3.2 TASLY Main Business
5.3.3 TASLY Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.3.4 TASLY Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.3.5 China TCM Recent Developments
5.4 China TCM
5.4.1 China TCM Profile
5.4.2 China TCM Main Business
5.4.3 China TCM Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.4.4 China TCM Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.4.5 China TCM Recent Developments
5.5 Yunnan Baiyao
5.5.1 Yunnan Baiyao Profile
5.5.2 Yunnan Baiyao Main Business
5.5.3 Yunnan Baiyao Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.5.4 Yunnan Baiyao Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.5.5 Yunnan Baiyao Recent Developments
5.6 Tongrentang
5.6.1 Tongrentang Profile
5.6.2 Tongrentang Main Business
5.6.3 Tongrentang Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.6.4 Tongrentang Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.6.5 Tongrentang Recent Developments
5.7 Jumpcan
5.7.1 Jumpcan Profile
5.7.2 Jumpcan Main Business
5.7.3 Jumpcan Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.7.4 Jumpcan Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.7.5 Jumpcan Recent Developments
5.8 Zhejiang Conba Pharmaceutical
5.8.1 Zhejiang Conba Pharmaceutical Profile
5.8.2 Zhejiang Conba Pharmaceutical Main Business
5.8.3 Zhejiang Conba Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.8.4 Zhejiang Conba Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.8.5 Zhejiang Conba Pharmaceutical Recent Developments
5.9 Green Valley Pharma
5.9.1 Green Valley Pharma Profile
5.9.2 Green Valley Pharma Main Business
5.9.3 Green Valley Pharma Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.9.4 Green Valley Pharma Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.9.5 Green Valley Pharma Recent Developments
5.10 Changbaishan Pharmaceutical
5.10.1 Changbaishan Pharmaceutical Profile
5.10.2 Changbaishan Pharmaceutical Main Business
5.10.3 Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.10.4 Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.10.5 Changbaishan Pharmaceutical Recent Developments
5.11 Zhejiang Kanglaite Pharmaceutical
5.11.1 Zhejiang Kanglaite Pharmaceutical Profile
5.11.2 Zhejiang Kanglaite Pharmaceutical Main Business
5.11.3 Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.11.4 Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.11.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
5.12 Qingfeng Pharmaceutical Group
5.12.1 Qingfeng Pharmaceutical Group Profile
5.12.2 Qingfeng Pharmaceutical Group Main Business
5.12.3 Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.12.4 Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.12.5 Qingfeng Pharmaceutical Group Recent Developments
5.13 Buchang Pharmaceutical
5.13.1 Buchang Pharmaceutical Profile
5.13.2 Buchang Pharmaceutical Main Business
5.13.3 Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.13.4 Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.13.5 Buchang Pharmaceutical Recent Developments
5.14 Livzon
5.14.1 Livzon Profile
5.14.2 Livzon Main Business
5.14.3 Livzon Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.14.4 Livzon Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.14.5 Livzon Recent Developments
5.15 ZBD Pharmaceutical
5.15.1 ZBD Pharmaceutical Profile
5.15.2 ZBD Pharmaceutical Main Business
5.15.3 ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.15.4 ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.15.5 ZBD Pharmaceutical Recent Developments
5.16 Chase Sun Pharmaceutical
5.16.1 Chase Sun Pharmaceutical Profile
5.16.2 Chase Sun Pharmaceutical Main Business
5.16.3 Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.16.4 Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.16.5 Chase Sun Pharmaceutical Recent Developments
5.17 Wuzhou Pharmaceutical
5.17.1 Wuzhou Pharmaceutical Profile
5.17.2 Wuzhou Pharmaceutical Main Business
5.17.3 Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.17.4 Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.17.5 Wuzhou Pharmaceutical Recent Developments
5.18 Yusheng Pharmaceutical
5.18.1 Yusheng Pharmaceutical Profile
5.18.2 Yusheng Pharmaceutical Main Business
5.18.3 Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.18.4 Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.18.5 Yusheng Pharmaceutical Recent Developments
5.19 Harbin Pharmaceutical Group
5.19.1 Harbin Pharmaceutical Group Profile
5.19.2 Harbin Pharmaceutical Group Main Business
5.19.3 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.19.4 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.19.5 Harbin Pharmaceutical Group Recent Developments
5.20 Fusen Pharmaceutical
5.20.1 Fusen Pharmaceutical Profile
5.20.2 Fusen Pharmaceutical Main Business
5.20.3 Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.20.4 Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.20.5 Fusen Pharmaceutical Recent Developments
5.21 Gerun Pharmaceutical
5.21.1 Gerun Pharmaceutical Profile
5.21.2 Gerun Pharmaceutical Main Business
5.21.3 Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.21.4 Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.21.5 Gerun Pharmaceutical Recent Developments
5.22 Shineway Pharmaceutical
5.22.1 Shineway Pharmaceutical Profile
5.22.2 Shineway Pharmaceutical Main Business
5.22.3 Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.22.4 Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.22.5 Shineway Pharmaceutical Recent Developments
5.23 Yiling Pharmaceutical
5.23.1 Yiling Pharmaceutical Profile
5.23.2 Yiling Pharmaceutical Main Business
5.23.3 Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.23.4 Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.23.5 Yiling Pharmaceutical Recent Developments
5.24 Harbin Pharmaceutical Group
5.24.1 Harbin Pharmaceutical Group Profile
5.24.2 Harbin Pharmaceutical Group Main Business
5.24.3 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Products, Services and Solutions
5.24.4 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Revenue (US$ Million) & (2018-2024)
5.24.5 Harbin Pharmaceutical Group Recent Developments
6 North America
6.1 North America Antiviral Traditional Chinese Medicine Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Antiviral Traditional Chinese Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antiviral Traditional Chinese Medicine Market Dynamics
11.1 Antiviral Traditional Chinese Medicine Industry Trends
11.2 Antiviral Traditional Chinese Medicine Market Drivers
11.3 Antiviral Traditional Chinese Medicine Market Challenges
11.4 Antiviral Traditional Chinese Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antiviral Traditional Chinese Medicine Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Antiviral Traditional Chinese Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Antiviral Traditional Chinese Medicine Market Size Share by Region (2018-2024)
Table 4. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Antiviral Traditional Chinese Medicine Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Antiviral Traditional Chinese Medicine Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Antiviral Traditional Chinese Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2018-2024)
Table 9. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2024-2029)
Table 11. North America Antiviral Traditional Chinese Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Antiviral Traditional Chinese Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Antiviral Traditional Chinese Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Antiviral Traditional Chinese Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Antiviral Traditional Chinese Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Antiviral Traditional Chinese Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Antiviral Traditional Chinese Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Antiviral Traditional Chinese Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Antiviral Traditional Chinese Medicine Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Antiviral Traditional Chinese Medicine Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Antiviral Traditional Chinese Medicine Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Antiviral Traditional Chinese Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2018-2024)
Table 24. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2024-2029)
Table 26. North America Antiviral Traditional Chinese Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Antiviral Traditional Chinese Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Antiviral Traditional Chinese Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Antiviral Traditional Chinese Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Antiviral Traditional Chinese Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Antiviral Traditional Chinese Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Antiviral Traditional Chinese Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Antiviral Traditional Chinese Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Antiviral Traditional Chinese Medicine Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Antiviral Traditional Chinese Medicine Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Antiviral Traditional Chinese Medicine Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiviral Traditional Chinese Medicine as of 2022)
Table 39. Date of Key Players Enter into Antiviral Traditional Chinese Medicine Market
Table 40. Global Antiviral Traditional Chinese Medicine Key Players Headquarters and Area Served
Table 41. Antiviral Traditional Chinese Medicine Product Solution and Service
Table 42. Global Antiviral Traditional Chinese Medicine Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Guangzhou Pharmaceutical Basic Information List
Table 45. Guangzhou Pharmaceutical Description and Business Overview
Table 46. Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Guangzhou Pharmaceutical (2018-2024)
Table 48. Guangzhou Pharmaceutical Recent Developments
Table 49. CR SANJIU Basic Information List
Table 50. CR SANJIU Description and Business Overview
Table 51. CR SANJIU Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of CR SANJIU (2018-2024)
Table 53. CR SANJIU Recent Developments
Table 54. TASLY Basic Information List
Table 55. TASLY Description and Business Overview
Table 56. TASLY Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of TASLY (2018-2024)
Table 58. TASLY Recent Developments
Table 59. China TCM Basic Information List
Table 60. China TCM Description and Business Overview
Table 61. China TCM Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 62. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of China TCM (2018-2024)
Table 63. China TCM Recent Developments
Table 64. Yunnan Baiyao Basic Information List
Table 65. Yunnan Baiyao Description and Business Overview
Table 66. Yunnan Baiyao Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 67. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Yunnan Baiyao (2018-2024)
Table 68. Yunnan Baiyao Recent Developments
Table 69. Tongrentang Basic Information List
Table 70. Tongrentang Description and Business Overview
Table 71. Tongrentang Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 72. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Tongrentang (2018-2024)
Table 73. Tongrentang Recent Developments
Table 74. Jumpcan Basic Information List
Table 75. Jumpcan Description and Business Overview
Table 76. Jumpcan Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 77. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Jumpcan (2018-2024)
Table 78. Jumpcan Recent Developments
Table 79. Zhejiang Conba Pharmaceutical Basic Information List
Table 80. Zhejiang Conba Pharmaceutical Description and Business Overview
Table 81. Zhejiang Conba Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 82. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Zhejiang Conba Pharmaceutical (2018-2024)
Table 83. Zhejiang Conba Pharmaceutical Recent Developments
Table 84. Green Valley Pharma Basic Information List
Table 85. Green Valley Pharma Description and Business Overview
Table 86. Green Valley Pharma Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 87. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Green Valley Pharma (2018-2024)
Table 88. Green Valley Pharma Recent Developments
Table 89. Changbaishan Pharmaceutical Basic Information List
Table 90. Changbaishan Pharmaceutical Description and Business Overview
Table 91. Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 92. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Changbaishan Pharmaceutical (2018-2024)
Table 93. Changbaishan Pharmaceutical Recent Developments
Table 94. Zhejiang Kanglaite Pharmaceutical Basic Information List
Table 95. Zhejiang Kanglaite Pharmaceutical Description and Business Overview
Table 96. Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 97. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Zhejiang Kanglaite Pharmaceutical (2018-2024)
Table 98. Zhejiang Kanglaite Pharmaceutical Recent Developments
Table 99. Qingfeng Pharmaceutical Group Basic Information List
Table 100. Qingfeng Pharmaceutical Group Description and Business Overview
Table 101. Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 102. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Qingfeng Pharmaceutical Group (2018-2024)
Table 103. Qingfeng Pharmaceutical Group Recent Developments
Table 104. Buchang Pharmaceutical Basic Information List
Table 105. Buchang Pharmaceutical Description and Business Overview
Table 106. Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 107. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Buchang Pharmaceutical (2018-2024)
Table 108. Buchang Pharmaceutical Recent Developments
Table 109. Livzon Basic Information List
Table 110. Livzon Description and Business Overview
Table 111. Livzon Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 112. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Livzon (2018-2024)
Table 113. Livzon Recent Developments
Table 114. ZBD Pharmaceutical Basic Information List
Table 115. ZBD Pharmaceutical Description and Business Overview
Table 116. ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 117. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of ZBD Pharmaceutical (2018-2024)
Table 118. ZBD Pharmaceutical Recent Developments
Table 119. Chase Sun Pharmaceutical Basic Information List
Table 120. Chase Sun Pharmaceutical Description and Business Overview
Table 121. Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 122. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Chase Sun Pharmaceutical (2018-2024)
Table 123. Chase Sun Pharmaceutical Recent Developments
Table 124. Wuzhou Pharmaceutical Basic Information List
Table 125. Wuzhou Pharmaceutical Description and Business Overview
Table 126. Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 127. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Wuzhou Pharmaceutical (2018-2024)
Table 128. Wuzhou Pharmaceutical Recent Developments
Table 129. Yusheng Pharmaceutical Basic Information List
Table 130. Yusheng Pharmaceutical Description and Business Overview
Table 131. Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 132. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Yusheng Pharmaceutical (2018-2024)
Table 133. Yusheng Pharmaceutical Recent Developments
Table 134. Harbin Pharmaceutical Group Basic Information List
Table 135. Harbin Pharmaceutical Group Description and Business Overview
Table 136. Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 137. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Harbin Pharmaceutical Group (2018-2024)
Table 138. Harbin Pharmaceutical Group Recent Developments
Table 139. Fusen Pharmaceutical Basic Information List
Table 140. Fusen Pharmaceutical Description and Business Overview
Table 141. Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 142. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Fusen Pharmaceutical (2018-2024)
Table 143. Fusen Pharmaceutical Recent Developments
Table 144. Gerun Pharmaceutical Basic Information List
Table 145. Gerun Pharmaceutical Description and Business Overview
Table 146. Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 147. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Gerun Pharmaceutical (2018-2024)
Table 148. Gerun Pharmaceutical Recent Developments
Table 149. Shineway Pharmaceutical Basic Information List
Table 150. Shineway Pharmaceutical Description and Business Overview
Table 151. Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 152. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Shineway Pharmaceutical (2018-2024)
Table 153. Shineway Pharmaceutical Recent Developments
Table 154. Yiling Pharmaceutical Basic Information List
Table 155. Yiling Pharmaceutical Description and Business Overview
Table 156. Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 157. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Yiling Pharmaceutical (2018-2024)
Table 158. Yiling Pharmaceutical Recent Developments
Table 159. Harbin Pharmaceutical Group Basic Information List
Table 160. Harbin Pharmaceutical Group Description and Business Overview
Table 161. Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Products, Services and Solutions
Table 162. Revenue (US$ Million) in Antiviral Traditional Chinese Medicine Business of Harbin Pharmaceutical Group (2018-2024)
Table 163. Harbin Pharmaceutical Group Recent Developments
Table 164. North America Antiviral Traditional Chinese Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 165. North America Antiviral Traditional Chinese Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 166. Europe Antiviral Traditional Chinese Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 167. Europe Antiviral Traditional Chinese Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 168. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 169. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 170. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 171. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Region (2018-2024)
Table 172. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Region (2024-2029)
Table 173. Latin America Antiviral Traditional Chinese Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 174. Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 175. Latin America Antiviral Traditional Chinese Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 176. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 177. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 178. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 179. Antiviral Traditional Chinese Medicine Market Trends
Table 180. Antiviral Traditional Chinese Medicine Market Drivers
Table 181. Antiviral Traditional Chinese Medicine Market Challenges
Table 182. Antiviral Traditional Chinese Medicine Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Traditional Chinese Medicine Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Antiviral Traditional Chinese Medicine Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Antiviral Traditional Chinese Medicine Market Share by Regions: 2022 VS 2029
Figure 4. Global Antiviral Traditional Chinese Medicine Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Antiviral Traditional Chinese Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Antiviral Traditional Chinese Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Antiviral Traditional Chinese Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Anti-HIV
Figure 11. Global Anti-HIV Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Anti-CVB
Figure 13. Global Anti-CVB Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Anti-HBV
Figure 15. Global Anti-HBV Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Anti-influenza Virus
Figure 17. Global Anti-influenza Virus Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Anti-herpes Virus
Figure 19. Global Anti-herpes Virus Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Product Picture of Other
Figure 21. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global Antiviral Traditional Chinese Medicine Market Size Share by Type: 2022 & 2029
Figure 23. North America Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2018-2029)
Figure 24. Europe Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2018-2029)
Figure 25. Asia-Pacific Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2018-2029)
Figure 26. Latin America Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2018-2029)
Figure 27. Middle East and Africa Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2018-2029)
Figure 28. Adult Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Children Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 30. Global Antiviral Traditional Chinese Medicine Market Size Share by Application: 2022 & 2029
Figure 31. North America Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2018-2029)
Figure 32. Europe Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2018-2029)
Figure 33. Asia-Pacific Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2018-2029)
Figure 34. Latin America Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2018-2029)
Figure 35. Middle East and Africa Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2018-2029)
Figure 36. Antiviral Traditional Chinese Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 37. Global Top 5 and Top 10 Players Antiviral Traditional Chinese Medicine Market Share in 2022
Figure 38. North America Antiviral Traditional Chinese Medicine Market Share by Country (2018-2029)
Figure 39. United States Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 40. Canada Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 41. Germany Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 42. France Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 43. U.K. Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 44. Italy Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 45. Russia Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 46. Nordic Countries Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 47. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Region (2018-2029)
Figure 48. China Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 49. Japan Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 50. South Korea Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 51. Southeast Asia Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 52. India Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 53. Australia Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 54. Latin America Antiviral Traditional Chinese Medicine Market Share by Country (2018-2029)
Figure 55. Mexico Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 56. Brazil Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 57. Middle East & Africa Antiviral Traditional Chinese Medicine Market Share by Country (2018-2029)
Figure 58. Turkey Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 60. UAE Antiviral Traditional Chinese Medicine Market Size (2018-2029) & (US$ Million)
Figure 61. Bottom-up and Top-down Approaches for This Report